Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hatakeyama

H. Hatakeyama, K. Kubota, andj. Nakano, Cellulose Chem. Technol 6, 521 (1972). [Pg.147]

Hatakeyama T, Nakamura K, Hatakeyama H (2000) Thermochim Acta 352-353 233 Dawsey TR, McCormick CL (1990) JMS-Rev Macromol Chem Phys C30 405 Potthast A, Rosenau ST, Sixta JH, Kosma P (2003) Polym 44 7 Marson GA, El Seoud OA (1999) J Appl Polym Sci 74 1355... [Pg.144]

Viruses that contain amino acid substitutions in the sialidase that impart resistance to the developed inhibitors have been isolated from serial passage of virus in the presence of drug in cell culture and from the clinical setting (reviewed in McKimm-Breschkin 2000 Zambon and Hayden 2001 Cinatl et al. 2007a Reece 2007). In addition, influenza B virus variants with reduced drug sensitivity have been isolated from previously untreated patients (Hurt et al. 2006 Hatakeyama et al. 2007). The types of mutations that are observed are sub-type specific. The mutations present in variants isolated from clinical samples are shown in Table 1, and their locations within the sialidase active site are shown diagrammatically in Fig. 9. [Pg.139]

Hagiwara T, Kijima-Suda I, Ido T, Ohrui H, Tomita K (1994) Inhibition of bacterial and viral sialidases by 3-fluoro-V-acetyIneuraminic acid, Carbohydr Res 263 167-172 Haskell TH, Peterson FE, Watson D, Plessas NR, Culbertson T (1970) Neuraminidase inhibition and viral chemotherapy, J Med Chem 13 697-704 Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors, JAMA 297 1435-1442 Hay AJ (1992) The action of adamantanamines against influenza A viruses inhibition of the M2 ion channel protein, Semin Virol 3 21-30... [Pg.148]

Hatakeyama S, Mori H, Kitano K, Yamada H, Nishizawa M (1994) Tetrahedron Lett 35 4367... [Pg.79]

Ueda T, Hatakeyama T, Kohno K, Kumon Y, Sakaki S. Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997 39 99-104. [Pg.91]


See other pages where Hatakeyama is mentioned: [Pg.112]    [Pg.395]    [Pg.347]    [Pg.227]    [Pg.154]    [Pg.57]    [Pg.131]    [Pg.207]    [Pg.79]    [Pg.95]    [Pg.143]    [Pg.223]    [Pg.342]    [Pg.61]    [Pg.290]    [Pg.339]    [Pg.296]    [Pg.314]    [Pg.314]    [Pg.316]    [Pg.436]    [Pg.513]    [Pg.513]    [Pg.630]    [Pg.283]    [Pg.304]    [Pg.361]    [Pg.362]    [Pg.21]    [Pg.116]    [Pg.316]    [Pg.140]    [Pg.140]    [Pg.142]    [Pg.143]    [Pg.144]    [Pg.174]    [Pg.406]    [Pg.123]    [Pg.270]    [Pg.351]    [Pg.170]    [Pg.225]    [Pg.212]    [Pg.341]   
See also in sourсe #XX -- [ Pg.103 , Pg.156 ]

See also in sourсe #XX -- [ Pg.92 , Pg.126 ]

See also in sourсe #XX -- [ Pg.92 , Pg.126 ]

See also in sourсe #XX -- [ Pg.257 ]

See also in sourсe #XX -- [ Pg.279 ]




SEARCH



Hatakeyama synthesis

Synthesis of Dysiherbaine (Hatakeyama), Jerangolid D (Marko) and ()-Spirolaxine Me Ether (Trost)

© 2024 chempedia.info